Kolexia
Fumoleau Pierre Oncologie médicale
Fumoleau Pierre
Oncologie médicale
Clcc Institut Curie
Paris, France
247 Activités
1.2 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Récidive tumorale locale Métastase tumorale Seconde tumeur primitive Cardiopathies Carcinomes Carcinome canalaire du sein Métastase lymphatique Tumeurs de l'ovaire

Collaborateurs

Voir plus
Coudert Bruno
Coudert Bruno
Centre Georges-François Leclerc, Dijon, France
Isambert Nicolas
Isambert Nicolas
Hôpital La Miletrie, Poitiers, France
Coutant Charles
Coutant Charles
Centre Georges-François Leclerc, Dijon, France
Pivot Xavier
Pivot Xavier
Centre Paul Strauss, Strasbourg, France

Industries

Voir plus
Lilly
2 collaboration(s)
Dernière en 2023
Advanced Accelerator Applications
2 collaboration(s)
Dernière en 2022
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
LAPATAM: Pharmacokinetics Study of Combined Treatment Lapatinib and Tamoxifen in Advanced/Metastatic Breast Cancer
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   07 mars 2024
MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery
Essai Clinique (Institut Curie)   26 janvier 2024
ER-One: A Double-blind Randomized Non-inferiority Trial of Erector Spinae Block (ESP) Versus Paravertebral Block (PVB) Before Breast Cancer Surgery: Effects on Acute Postoperative Pain.
Essai Clinique (Institut Curie)   26 janvier 2024
LIBERTYLUNG: LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer
Essai Clinique (Institut Curie)   08 janvier 2024
Curie-O-SA: COVID-19 Study of the Serological Response Against the SARS-CoV-2 Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur
Essai Clinique (Institut Curie)   28 novembre 2023
PREMETHEP: Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Essai Clinique (Centre Georges-François Leclerc)   09 octobre 2023
Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors.
Reproductive biomedicine online   19 janvier 2022
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.
Cancer chemotherapy and pharmacology   08 janvier 2022
1707P A single G-CSF administration is enough to limit neutropenia in patients treated by eribulin
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Adapting to the SARS-CoV2 pandemic: Experience of the Curie Institute.
Bulletin du cancer   26 juin 2021